Shire to acquire Movetis
TURNHOUT, Belgium British drug maker Shire will acquire Belgian drug maker Movetis for $567 million, Movetis said.
Shire, a global specialty biopharmaceutical company, announced Friday that it has officially opened a new representative office in Japan and has appointed Soh Fujiwara as Managing Director for Japanese operations.